Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 3
1984 1
1985 2
1986 5
1987 4
1988 3
1989 7
1990 3
1991 7
1992 4
1993 1
1994 6
1995 6
1996 13
1997 8
1998 12
1999 2
2000 7
2001 14
2002 10
2003 10
2004 11
2005 12
2006 12
2007 14
2008 13
2009 11
2010 19
2011 11
2012 15
2013 15
2014 13
2015 15
2016 10
2017 9
2018 9
2019 11
2020 10
2021 14
2022 9
2023 10
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

341 results

Results by year

Filters applied: . Clear all
Page 1
Uveitis for the non-ophthalmologist.
Burkholder BM, Jabs DA. Burkholder BM, et al. Among authors: jabs da. BMJ. 2021 Feb 3;372:m4979. doi: 10.1136/bmj.m4979. BMJ. 2021. PMID: 33536186 Review.
The standardisation of uveitis nomenclature (SUN) project.
Jabs DA, McCluskey P, Palestine AG, Thorne JE; Standardization of Uveitis Nomenclature (SUN) Working Group. Jabs DA, et al. Clin Exp Ophthalmol. 2022 Sep 27:10.1111/ceo.14175. doi: 10.1111/ceo.14175. Online ahead of print. Clin Exp Ophthalmol. 2022. PMID: 36164924 Free PMC article. Review.
Epidemiology of uveitis.
Jabs DA. Jabs DA. Ophthalmic Epidemiol. 2008 Sep-Oct;15(5):283-4. doi: 10.1080/09286580802478724. Ophthalmic Epidemiol. 2008. PMID: 18850463 No abstract available.
Immunosuppression for the Uveitides.
Jabs DA. Jabs DA. Ophthalmology. 2018 Feb;125(2):193-202. doi: 10.1016/j.ophtha.2017.08.007. Epub 2017 Sep 20. Ophthalmology. 2018. PMID: 28942074 Free PMC article. Review.
Cidofovir.
Jabs DA. Jabs DA. Arch Ophthalmol. 1997 Jun;115(6):785-6. doi: 10.1001/archopht.1997.01100150787016. Arch Ophthalmol. 1997. PMID: 9194731 Review. No abstract available.
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group. Thorne JE, et al. Among authors: jabs da. Ophthalmology. 2019 Feb;126(2):283-295. doi: 10.1016/j.ophtha.2018.08.021. Epub 2018 Sep 27. Ophthalmology. 2019. PMID: 30269924 Free PMC article. Clinical Trial.
Scleritis in Lyme Disease.
Berkenstock MK, Long K, Miller JB, Burkholder BB, Aucott JN, Jabs DA. Berkenstock MK, et al. Among authors: jabs da. Am J Ophthalmol. 2022 Sep;241:139-144. doi: 10.1016/j.ajo.2022.04.017. Epub 2022 May 2. Am J Ophthalmol. 2022. PMID: 35513033
341 results